Download full-text PDF |
Source |
---|
Colorectal Dis
October 2020
Clinical Operational Research Unit, University College London, London, UK.
Aim: Lung metastases from colorectal cancer are resected in selected patients in the belief that this confers a significant survival advantage. It is generally assumed that the 5-year survival of these patients would be near zero without metastasectomy. We tested the clinical effectiveness of this practice in Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC), a randomized, controlled noninferiority trial.
View Article and Find Full Text PDFTrials
December 2019
Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Falmer, BN1 9RX, UK.
Background: Lung metastasectomy in the treatment of advanced colorectal cancer has been widely adopted without good evidence of survival or palliative benefit. We aimed to test its effectiveness in a randomised controlled trial (RCT).
Methods: Multidisciplinary teams in 13 hospitals recruited participants with potentially resectable lung metastases to a multicentre, two-arm RCT comparing active monitoring with or without metastasectomy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!